BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:JNJ-78934804 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of JNJ-78934804\, from ClinicalTrials.gov es
 timates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07577843-22@assetmemo.bio
DTSTAMP:20261121T005010Z
DTSTART;VALUE=DATE:20280612
DTEND;VALUE=DATE:20280613
SUMMARY:JNJ-78934804: Phase 3 readout est. (NCT07577843)
DESCRIPTION:JNJ-78934804\, phase 3\, Crohn's Disease.\nStudy: A Study of JN
 J-78934804 in Participants With Moderately to Severely Active Crohn's Dise
 ase\nEstimated primary completion: 12 June 2028. This is a ClinicalTrials.
 gov estimate\, not a confirmed readout date\, and it can move.\nDrug page:
  https://assetmemo.bio/drug/jnj-78934804#upcoming-events\nRegistry record:
  https://clinicaltrials.gov/study/NCT07577843
URL:https://assetmemo.bio/drug/jnj-78934804#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07577856-22@assetmemo.bio
DTSTAMP:20261121T005010Z
DTSTART;VALUE=DATE:20280811
DTEND;VALUE=DATE:20280812
SUMMARY:JNJ-78934804: Phase 3 readout est. (NCT07577856)
DESCRIPTION:JNJ-78934804\, phase 3\, Ulcerative Colitis.\nStudy: A Study of
  JNJ-78934804 in Participants With Moderately to Severely Active Ulcerativ
 e Colitis\nEstimated primary completion: 11 August 2028. This is a Clinica
 lTrials.gov estimate\, not a confirmed readout date\, and it can move.\nDr
 ug page: https://assetmemo.bio/drug/jnj-78934804#upcoming-events\nRegistry
  record: https://clinicaltrials.gov/study/NCT07577856
URL:https://assetmemo.bio/drug/jnj-78934804#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
